BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23848971)

  • 1. Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening.
    Chan FY; Sun N; Neves MA; Lam PC; Chung WH; Wong LK; Chow HY; Ma DL; Chan PH; Leung YC; Chan TH; Abagyan R; Wong KY
    J Chem Inf Model; 2013 Aug; 53(8):2131-40. PubMed ID: 23848971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials.
    Paradis-Bleau C; Beaumont M; Sanschagrin F; Voyer N; Levesque RC
    Bioorg Med Chem; 2007 Feb; 15(3):1330-40. PubMed ID: 17157508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ.
    Singh P; Jindal B; Surolia A; Panda D
    Biochemistry; 2012 Jul; 51(27):5434-42. PubMed ID: 22703373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic inhibitors of bacterial cell division targeting the GTP-binding site of FtsZ.
    Ruiz-Avila LB; Huecas S; Artola M; Vergoñós A; Ramírez-Aportela E; Cercenado E; Barasoain I; Vázquez-Villa H; Martín-Fontecha M; Chacón P; López-Rodríguez ML; Andreu JM
    ACS Chem Biol; 2013 Sep; 8(9):2072-83. PubMed ID: 23855511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and screening of inhibitors for an essential bacterial GTPase, Der.
    Hwang J; Tseitin V; Ramnarayan K; Shenderovich MD; Inouye M
    J Antibiot (Tokyo); 2012 May; 65(5):237-43. PubMed ID: 22377538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GTP analogue inhibits polymerization and GTPase activity of the bacterial protein FtsZ without affecting its eukaryotic homologue tubulin.
    Läppchen T; Hartog AF; Pinas VA; Koomen GJ; den Blaauwen T
    Biochemistry; 2005 May; 44(21):7879-84. PubMed ID: 15910002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anti-tuberculosis agents that target the cell-division protein FtsZ.
    Lin Y; Zhu N; Han Y; Jiang J; Si S
    J Antibiot (Tokyo); 2014 Sep; 67(9):671-6. PubMed ID: 24984796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action.
    Artola M; Ruiz-Avila LB; Vergoñós A; Huecas S; Araujo-Bazán L; Martín-Fontecha M; Vázquez-Villa H; Turrado C; Ramírez-Aportela E; Hoegl A; Nodwell M; Barasoain I; Chacón P; Sieber SA; Andreu JM; López-Rodríguez ML
    ACS Chem Biol; 2015 Mar; 10(3):834-43. PubMed ID: 25486266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics.
    Wang J; Galgoci A; Kodali S; Herath KB; Jayasuriya H; Dorso K; Vicente F; González A; Cully D; Bramhill D; Singh S
    J Biol Chem; 2003 Nov; 278(45):44424-8. PubMed ID: 12952956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.
    Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY
    Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and in vitro inhibition studies of Bacillus anthracis FtsZ: a potential antibacterial target.
    Park HC; Gedi V; Cho JH; Hyun JW; Lee KJ; Kang J; So B; Yoon MY
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3263-70. PubMed ID: 24510482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico study and validation of phosphotransacetylase (PTA) as a putative drug target for Staphylococcus aureus by homology-based modelling and virtual screening.
    Morya VK; Dewaker V; Kim EK
    Appl Biochem Biotechnol; 2012 Dec; 168(7):1792-805. PubMed ID: 23054816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptide CRAMP (16-33) stalls bacterial cytokinesis by inhibiting FtsZ assembly.
    Ray S; Dhaked HP; Panda D
    Biochemistry; 2014 Oct; 53(41):6426-9. PubMed ID: 25294259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ.
    Stokes NR; Baker N; Bennett JM; Chauhan PK; Collins I; Davies DT; Gavade M; Kumar D; Lancett P; Macdonald R; Macleod L; Mahajan A; Mitchell JP; Nayal N; Nayal YN; Pitt GR; Singh M; Yadav A; Srivastava A; Czaplewski LG; Haydon DJ
    Bioorg Med Chem Lett; 2014 Jan; 24(1):353-9. PubMed ID: 24287381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.
    Margalit DN; Romberg L; Mets RB; Hebert AM; Mitchison TJ; Kirschner MW; RayChaudhuri D
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11821-6. PubMed ID: 15289600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus.
    Vijayalakshmi P; Nisha J; Rajalakshmi M
    Interdiscip Sci; 2014 Dec; 6(4):331-9. PubMed ID: 25519150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong FtsZ is with the force: mechanisms to constrict bacteria.
    Mingorance J; Rivas G; Vélez M; Gómez-Puertas P; Vicente M
    Trends Microbiol; 2010 Aug; 18(8):348-56. PubMed ID: 20598544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation.
    Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D
    J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus.
    Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J
    SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.